How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Factorial Energy (NASDAQ:FAC) is focusing on execution, customer validation and a capital-light manufacturing strategy following its recent Nasdaq listing, CEO and co-founder Dr. Siyu Huang said ...
Recursion Pharmaceuticals (RXRX) ended the recent trading session at $3.34, demonstrating a +1.21% change from the preceding day's closing price. The stock outpaced the S&P 500's daily gain of 0.38%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results